Evidence map›Paper›PMID 30683768›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

Detection Rate of

Cordula A Jilg, Vanessa Drendel, H Christian Rischke, Teresa I Beck, Kathrin Reichel, Malte Krönig, Ulrich Wetterauer, Wolfgang Schultze-Seemann, Philipp T Meyer, Werner Vach

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Prostate international · 2025
    Article
  4. Article
  5. Review
  6. Size and SUVThe Prostate · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. [Salvage lymphadenectomy for recurrent prostate cancer].Urologie (Heidelberg, Germany) · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Head-to-Head Comparison ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Cordula A JilgDepartment of Urology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany cordula.jilg@uniklinik-freiburg.de.
Vanessa DrendelInstitute for Pathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
H Christian RischkeDepartment of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Teresa I BeckDepartment of Nuclear Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Kathrin ReichelDepartment of Urology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Malte KrönigDepartment of Urology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ulrich WetterauerDepartment of Urology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wolfgang Schultze-SeemannDepartment of Urology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Philipp T MeyerDepartment of Nuclear Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Werner VachDepartment of Orthopedics and Traumatology, University Hospital Basel, Switzerland; and.
University of Freiburg · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate detection of prostate cancer lymph node metastases (LNM) through PET/CT before lymphadenectomy is crucial for successful therapy. PET/CT with choline derivatives used to be the standard tool for imaging metastases, whereas

Indexed as

Positron Emission Tomography Computed TomographyTumor BurdenAgedCholineEdetic AcidGallium IsotopesGallium RadioisotopesHumansLymphatic MetastasisLymph Node ExcisionMaleMembrane GlycoproteinsOrganometallic CompoundsProstatic NeoplasmsRetrospective StudiesCholineEdetic Acidfluorocholinegallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesMembrane GlycoproteinsN,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acidOrganometallic Compoundscholine-PET/CTdetection ratelymph node metastasesprostate cancerPSMA-PET/CT

Identifiers

PMID30683768
PMCPMC6604697
OpenAlexW2913896904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.